NOVAVAX INC: accounts_payable
| Value | {"amount": 6790000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-09-30) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/09e16bb3-25c3-48d0-99d2-f667c7da0c50
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-18-057994Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/accounts-payable/2018-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/09e16bb3-25c3-48d0-99d2-f667c7da0c50
History
- no predecessors — first report